Affordable Access

Publisher Website

Interaction of Angiogenesis Inhibitor TNP-470 with Basic Fibroblast Growth Factor Receptors

Authors
Journal
Journal of Surgical Research
0022-4804
Publisher
Elsevier
Publication Date
Volume
92
Issue
1
Identifiers
DOI: 10.1006/jsre.2000.5854
Keywords
  • Tnp-470
  • Agm-1470
  • Wound Healing
  • Basic Fibroblast Growth Factor
  • Basic Fibroblast Growth Factor Receptor
Disciplines
  • Biology

Abstract

Abstract TNP-470 is a synthetic analogue of fumagillin that acts as a potent angiogenesis inhibitor. Recently, our laboratory demonstrated that systemic administration of TNP-470 (5.0 mg/kg) decreased the rate of cutaneous wound healing by greater than 20%. In this study, we tested the hypothesis that TNP-470 interferes with the wound repair-stimulating action of basic fibroblast growth factor (bFGF) by competing with endogenous bFGF for its binding sites on the receptor protein. The influence of TNP-470 was examined in vitro in a ligand competition assay of high- and low-affinity receptor binding to 125I-bFGF in NIH/3T3 cells. Results demonstrated that recognition of 125I-bFGF by low-affinity growth factor binding sites was significantly decreased ( P < 0.01) in the presence of TNP-470. However, TNP-470 inhibition of radiolabeled bFGF binding to high-affinity sites was not significantly affected ( P = 0.07). In view of recent studies demonstrating that the low-affinity receptors of bFGF were heparan sulfate proteoglycans, we suggest that the influence of TNP-470 on diminished wound healing is due to its direct recognition by these molecules.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Interaction of angiogenesis inhibitor TNP-470 with...

on Journal of Surgical Research July 2000

[An angiogenesis inhibitor: TNP-470].

on Bulletin du Cancer June 2000

Cytostatic inhibition of endothelial cell growth b...

on British Journal of Cancer Feb 01, 1994

Angiogenesis inhibitor TNP-470 reduces human pancr...

on Journal of Gastrointestinal Su... Jan 01, 2001
More articles like this..